117859-47-9

Upstream product

• 117858-83-0 N-benzyl-1,4-dideoxy-2,3:5,6-di-O-isopropylidene-1,4-imino-D-allitol 
• 3969-61-7 2,3:5,6-di-O-isopropylidene-D-gulitol 
• 117859-45-7 methanesulfonic acid (S)-((4R)-2,2-dimethyl-[1,3]dioxolan-4-yl)-((4S,5S)-5-methanesulfonyloxymethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-methyl ester 
• 29474-78-0 D-allono-1,4-lactone 
• 27108-15-2 2,3:5,6-di-O-isopropylidene-D-allono-1,4-lactone 
• 73209-94-6 (1R)-(2,2-dimethyl-1,3-dioxolan-4-yl)-((4R,5S)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)methanol 
• 17480-69-2 (S)-N-benzyl-1-phenylethylamine 
• 1393792-72-7 tert-butyl (4R,5S,E)-4,5-dihydroxy-4,5-O-isopropylidene-6-(tert-butyldimethylsilyloxy)hex-2-enoate 
• 67642-42-6 2,3,5,6-di-O-isopropylidene-D-gulono-1,4-lactone 
• 6322-07-2 D-gulono-1,4-lactone 

Downstream Products

• 117858-84-1 N-benzyl-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol 
• 914784-16-0 N-benzyl-2,5-dideoxy-2,5-imino-3,4-O-isopropylidene-L-ribose 
• 914784-21-7 methyl 4,6-O-benzylidene-2-deoxy-2-[(1Z)-2,5-(benzylimino)-1,2,5-trideoxy-3,4-O-isopropylidene-L-ribitol-1C-ylidene]-α-D-erythro-hexopyranosid-3-ulose 
• 914784-20-6 methyl 4,6-O-benzylidene-2-deoxy-2-[(1E)-2,5-(benzylimino)-1,2,5-trideoxy-3,4-O-isopropylidene-L-ribitol-1C-ylidene]-α-D-erythro-hexopyranosid-3-ulose 
• 914784-27-3 methyl 2-deoxy-2-[(1R/S)-2,5-(benzylimino)-1,2,5-trideoxy-3,4-O-isopropylidene-1-(phenylthio)-L-ribitol-1C-yl]-α-D-allopyranoside 
• 914784-17-1 methyl 4,6-O-benzylidene-2-deoxy-2-[(1R/1S)-2,5-(benzylimino)-2,5-dideoxy-3,4-O-isopropylidene-L-ribitol-1C-yl]-α-D-ribo-hexopyranosid-3-ulose 
• 914784-22-8 methyl 4,6-O-benzylidene-2-deoxy-2-[(1Z)-2,5-(benzylimino)-1,2,5-trideoxy-3,4-O-isopropylidene-L-ribitol-1C-ylidene]-α-D-arabino-hexopyranoside 
• 914784-18-2 methyl 4,6-O-benzylidene-2-deoxy-2-[(1R/1S)-2,5-(benzylimino)-2,5-dideoxy-3,4-O-isopropylidene-L-ribitol-1C-yl]-α-D-allopyranoside 
• 914784-26-2 methyl 4,6-O-benzylidene-2-deoxy-2-[(1R/S)-2,5-(benzylimino)-1,2,5-trideoxy-3,4-O-isopropylidene-1-(phenylthio)-L-ribitol-1C-yl]-α-D-allopyranoside 
• 914784-25-1 methyl 4,6-O-benzylidene-2-deoxy-2-[(1R/S)-2,5-(benzylimino)-1,2,5-trideoxy-3,4-O-isopropylidene-1-(phenylthio)-L-ribitol-1C-yl]-α-D-ribo-hexopyranosid-3-ulose 
• 95341-64-3 (2S,3R,4S)-3,4-dihydroxypyrrolidine-2-carboxylic acid 
• 117770-18-0 N-benzyl-1,4-dideoxy-1,4-imino-D-ribitol 
• 117770-16-8 1,4-dideoxy-1,4-imino-D-allitol hydrochloride 

Relevant academic research and scientific papers

Stereospecific cyclization strategies for α,ε-dihydroxy-β-amino esters: Asymmetric syntheses of imino and amino sugars

A range of biologically significant imino and amino sugars [1,4-dideoxy-1,4-imino-D-allitol, 3,6-dideoxy-3,6-imino-L-allonic acid, (3 R,4 S)-3,4-dihydroxy-L-proline, 1,5-anhydro-4-deoxy-4-amino-D-glucitol, and 1,5-anhydro-4-deoxy-4-amino-L-iditol] has bee

Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as α-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies

Novel α-mannosidase inhibitors of the type (2R,3R,4S)-2-({[(1R)-2-hydroxy-1-arylethyl]amino}methyl)pyrrolidine-3,4-diol have been prepared and assayed for their anticancer activities. Compound 30 with the aryl group = 4-trifluoromethylbiphenyl inhibits the proliferation of primary cells and cell lines of different origins, irrespective of Bcl-2 expression levels, inducing a G2/Mcell cycle arrest and by modification of genes involved in cell cycle progression and survival.

NOVEL DIHYDROXYPYRROLIDINE DERIVATIVES AS ANTI-CANCER AGENTS

The present invention provides new dihydroxypyrrolidine derivatives for use as medicaments. The compounds are useful in the treatment in cancer, in particular non-solid neoplasms.

POLYHYDROXYLATED PYRROLIDINES FROM SUGAR LACTONES: SYNTHESIS OF 1,4-DIDEOXY-1,4-IMINO-D-GLUCITOL FROM D-GALACTONOLACTONE AND SYNTHESES OF 1,4-DIDEOXY-1,4-IMINO-D-ALLITOL, 1,4-DIDEOXY-1,4-IMINO-D-RIBITOL, AND (2S,3R,4S)-3,4-DIHYDROXYPROLINE FROM D-GULONOLACTONE

The use of readily available sugar lactones in the synthesis of polyhydroxylated pyrrolidines is illustrated by the preparation of the glucosidase inhibitor 1,4-dideoxy-1,4-imino-D-glucitol from D-galactonolactone and by the conversion of D-gulonolactone into 1,4-dideoxy-1,4-imino-D-allitol, 1,4-dideoxy-1,4-imino-D-ribitol, and (2S,3R,4S)-3,4-dihydroxyproline.